Human beta-defensin-3 producing cells in septic implant loosening

[1]  Xian-kai Huang,et al.  Effects of human β-defensin-3 on biofilm formation‑regulating genes dltB and icaA in Staphylococcus aureus. , 2014, Molecular medicine reports.

[2]  Guangshun Wang,et al.  Human Antimicrobial Peptides and Proteins , 2014, Pharmaceuticals.

[3]  Jiying Chen,et al.  Human beta-defensin-3 for the diagnosis of periprosthetic joint infection and loosening. , 2014, Orthopedics.

[4]  T. Pritts,et al.  Human beta-defensin 3: a novel inhibitor of Staphylococcus-produced biofilm production. Commentary on "Human β-defensin 3 inhibits antibiotic-resistant Staphylococcus biofilm formation". , 2014, The Journal of surgical research.

[5]  Seok-Woo Chang,et al.  Antibacterial efficacy of a human β-defensin-3 peptide on multispecies biofilms. , 2013, Journal of endodontics.

[6]  Tomoyuki Saito,et al.  Different diagnostic properties of C-reactive protein, real-time PCR, and histopathology of frozen and permanent sections in diagnosis of periprosthetic joint infection , 2013, Acta orthopaedica.

[7]  Lili Chen,et al.  The induction expression of human β-defensins in gingival epithelial cells and fibroblasts. , 2013, Archives of oral biology.

[8]  S. Tarasov,et al.  β-Defensin 2 and 3 Promote the Uptake of Self or CpG DNA, Enhance IFN-α Production by Human Plasmacytoid Dendritic Cells, and Promote Inflammation , 2013, The Journal of Immunology.

[9]  R. Burgkart,et al.  Antimicrobial peptides and proinflammatory cytokines in periprosthetic joint infection. , 2013, The Journal of bone and joint surgery. American volume.

[10]  Carla Renata Arciola,et al.  Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials. , 2012, Biomaterials.

[11]  J. Brender,et al.  Does Cholesterol Play a Role in the Bacterial Selectivity of Antimicrobial Peptides? , 2012, Front. Immun..

[12]  Zeyu Huang,et al.  Mini-midvastus versus medial parapatellar approach in TKA: muscle damage and inflammation markers. , 2012, Orthopedics.

[13]  E. Gómez-Barrena,et al.  PCR-hybridization after sonication improves diagnosis of implant-related infection , 2012, Acta orthopaedica.

[14]  J. Dorin,et al.  β-Defensins: Multifunctional Modulators of Infection, Inflammation and More? , 2012, Journal of Innate Immunity.

[15]  Yong-gang Zhou,et al.  Comparison of the effects of human β-defensin 3, vancomycin, and clindamycin on Staphylococcus aureus biofilm formation. , 2012, Orthopedics.

[16]  J. Parvizi,et al.  New definition for periprosthetic joint infection. , 2011, The Journal of arthroplasty.

[17]  S. Giannini,et al.  Scenery of Staphylococcus implant infections in orthopedics. , 2011, Future microbiology.

[18]  J. Parvizi,et al.  New Definition for Periprosthetic Joint Infection: From the Workgroup of the Musculoskeletal Infection Society , 2011, Clinical orthopaedics and related research.

[19]  T. Hehlgans,et al.  Human β-Defensin 2 and 3 and Their Mouse Orthologs Induce Chemotaxis through Interaction with CCR2 , 2010, The Journal of Immunology.

[20]  K. Leung.  99mTc-Human β-defensin-3 , 2009 .

[21]  Y. Konttinen,et al.  Tissues and Septic Synovial Membranes Around Total Hip Implants Increased Expression of Toll-like Receptors in Aseptic Loose , 2009 .

[22]  H. Kristensen,et al.  Antimicrobial peptides effectively kill a broad spectrum of Listeria monocytogenes and Staphylococcus aureus strains independently of origin, sub-type, or virulence factor expression , 2008, BMC Microbiology.

[23]  S. Kurtz,et al.  Infection burden for hip and knee arthroplasty in the United States. , 2008, The Journal of arthroplasty.

[24]  M. Lederman,et al.  Human β-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2 , 2007, Proceedings of the National Academy of Sciences.

[25]  A. Soruri,et al.  β‐Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved , 2007, European journal of immunology.

[26]  Y. Konttinen,et al.  Toll-like receptors in the interface membrane around loosening total hip replacement implants. , 2007, Journal of biomedical materials research. Part A.

[27]  W. Zimmerli,et al.  Prosthetic-joint-associated infections , 2006 .

[28]  Miguel A R B Castanho,et al.  Cell-penetrating peptides and antimicrobial peptides: how different are they? , 2006, The Biochemical journal.

[29]  Ayyalusamy Ramamoorthy,et al.  The human beta-defensin-3, an antibacterial peptide with multiple biological functions. , 2006, Biochimica et biophysica acta.

[30]  W. Florio,et al.  In Vitro Bactericidal Activity of Human β-Defensin 3 against Multidrug-Resistant Nosocomial Strains , 2006, Antimicrobial Agents and Chemotherapy.

[31]  W. Zimmerli,et al.  Infection and musculoskeletal conditions: Prosthetic-joint-associated infections. , 2006, Best practice & research. Clinical rheumatology.

[32]  L. Samaranayake,et al.  Expression of human β-defensin-3 in gingival epithelia , 2005 .

[33]  M. Ghannoum,et al.  Human Beta-defensins: Differential Activity against Candidal Species and Regulation by Candida albicans , 2005, Journal of dental research.

[34]  L. Samaranayake,et al.  Expression of human beta-defensin-3 in gingival epithelia. , 2005, Journal of periodontal research.

[35]  T. Kaku,et al.  Effect of defensin peptides on eukaryotic cells: primary epithelial cells, fibroblasts and squamous cell carcinoma cell lines. , 2004, Journal of dermatological science.

[36]  A. Gristina.  Biomaterial-centered infection: microbial adhesion versus tissue integration. 1987. , 2004, Clinical orthopaedics and related research.

[37]  M. Bokarewa,et al.  Intraarticular release and accumulation of defensins and bactericidal/permeability-increasing protein in patients with rheumatoid arthritis. , 2003, The Journal of rheumatology.

[38]  D. Hoover,et al.  Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human β-defensin 3 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  T. Pufe,et al.  Antimicrobial peptides are expressed and produced in healthy and inflamed human synovial membranes , 2002, The Journal of pathology.

[40]  R. Siebert,et al.  The novel human beta-defensin-3 is widely expressed in oral tissues. , 2002, European journal of oral sciences.

[41]  Rainer Hedrich,et al.  Identification of a novel, multifunctional β-defensin (human β-defensin 3) with specific antimicrobial activity , 2001, Cell and Tissue Research.

[42]  J. Schröder,et al.  Isolation and Characterization of Human β-Defensin-3, a Novel Human Inducible Peptide Antibiotic* , 2001, The Journal of Biological Chemistry.

[43]  S. Pileri,et al.  The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. , 1998, Journal of clinical pathology.

[44]  A. Gristina,et al.  Biomaterial-centered infection: microbial adhesion versus tissue integration. , 1987, Science.

[45]  B. Brause.  Infections associated with prosthetic joints. , 1986, Clinics in rheumatic diseases.

[46]  M. Fishbein,et al.  Demonstration of myoglobin and CK-M in myocardium. Comparison of five fixation methods and three immunohistochemical techniques. , 1985, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[47]  Beck Jh,et al.  Immunoperoxidase localization of treponema pallidum: its use in formaldehyde-fixed and paraffin-embedded tissue sections. , 1979 .

[48]  J. Bigbee,et al.  Immunoperoxidase localization of treponema pallidum: its use in formaldehyde-fixed and paraffin-embedded tissue sections. , 1979, Archives of pathology & laboratory medicine.